📣 VC round data is live. Check it out!

Definitive Healthcare Valuation Multiples

Discover revenue and EBITDA valuation multiples for Definitive Healthcare and similar public comparables like JLK, DocCheck, CareCloud, Seer and more.

Definitive Healthcare Overview

About Definitive Healthcare

Definitive Healthcare Corp is a provider of healthcare commercial intelligence. Its SaaS-based healthcare commercial intelligence platform is designed to provide comprehensive and accurate information on the healthcare ecosystem in the U.S. The platform uses deep analytics and data science to help customers develop data-driven strategic decisions, such as finding new markets to enter, building comprehensive go-to-market strategies, accessing tactical information to help target the right decision makers, and improving win rates with detailed contextual information. The company derives substantially all of its revenue from the sale of subscription fees for access to its platform and stand-ready support. Geographically, it derives a majority of its revenue from the United States.


Founded

2021

HQ

United States

Employees

782

Financials (LTM)

Revenue: $235M
EBITDA: $65M

EV

$80M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Definitive Healthcare Financials

Definitive Healthcare reported last 12-month revenue of $235M and EBITDA of $65M.

In the same LTM period, Definitive Healthcare generated $190M in gross profit, $65M in EBITDA, and $32M in net income.

Revenue (LTM)


Definitive Healthcare P&L

In the most recent fiscal year, Definitive Healthcare reported revenue of $242M and EBITDA of $70M.

Definitive Healthcare is profitable as of last fiscal year, with gross margin of 76%, EBITDA margin of 29%, and net margin of 14%.

See analyst estimates for Definitive Healthcare
LTMLast FY202320242025202620272028
Revenue$235M$242M$251M$252M$242M
Gross Profit$190M$183M$204M$197M$183M
Gross Margin81%76%81%78%76%
EBITDA$65M$70M($241M)($567M)($142M)
EBITDA Margin28%29%(96%)(225%)(59%)
EBIT Margin23%25%(12%)(4%)(9%)
Net Profit$32M$35M($202M)($413M)($139M)
Net Margin13%14%(80%)(164%)(58%)
Net Debt—$1M———

Financial data powered by Morningstar, Inc.

Definitive Healthcare Stock Performance

Definitive Healthcare has current market cap of $89M, and enterprise value of $80M.

Market Cap Evolution


Definitive Healthcare's stock price is $0.84.

Definitive Healthcare share price decreased by 11.8% in the last 30 days, and by 74.6% in the last year.

Definitive Healthcare has an EPS (earnings per share) of $0.33.

See more trading valuation data for Definitive Healthcare
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$80M$89M4.0%-11.8%-34.3%-74.6%$0.33

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Definitive Healthcare Valuation Multiples

Definitive Healthcare trades at 0.3x EV/Revenue multiple, and 1.2x EV/EBITDA.

See NTM and 2027E valuation multiples for Definitive Healthcare

EV / Revenue (LTM)


Definitive Healthcare Financial Valuation Multiples

As of May 19, 2026, Definitive Healthcare has market cap of $89M and EV of $80M.

Definitive Healthcare has a P/E ratio of 2.8x.

LTMLast FY202320242025202620272028
EV/Revenue0.3x0.3x0.3x0.3x0.3x
EV/EBITDA1.2x1.1x(0.3x)(0.1x)(0.6x)
EV/EBIT1.5x1.4x(2.6x)(8.3x)(3.9x)
EV/Gross Profit0.4x0.4x0.4x0.4x0.4x
P/E2.8x2.5x(0.4x)(0.2x)(0.6x)
EV/FCF2.4x2.2x2.1x1.8x2.2x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Definitive Healthcare Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Definitive Healthcare Margins & Growth Rates

Definitive Healthcare decreased revenue by 7% and EBITDA by 19% in the last fiscal year.

In the most recent fiscal year, Definitive Healthcare reported gross margin of 76%, EBITDA margin of 29%, and net margin of 14%.

See estimated margins and future growth rates for Definitive Healthcare

Definitive Healthcare Margins

Last FY202420252026202720282029
Gross Margin76%78%76%80%
EBITDA Margin29%(225%)(59%)26%
EBIT Margin25%(4%)(9%)21%
Net Margin14%(164%)(58%)12%
FCF Margin15%18%15%13%

Definitive Healthcare Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth(7%)0%(4%)(7%)
Gross Profit Growth(2%)(3%)(7%)(2%)
EBITDA Growth(19%)135%(75%)(140%)
EBIT Growth(23%)(68%)111%(324%)
Net Profit Growth(24%)104%(66%)(119%)
FCF Growth(24%)20%(19%)(24%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Definitive Healthcare Operational KPIs

Definitive Healthcare's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.3M for the same period.

Definitive Healthcare's Rule of 40 is 18% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Definitive Healthcare's Rule of X is 7% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Definitive Healthcare
LTMLast FY202320242025202620272028
Rule of 4023%18%———
Bessemer Rule of X16%7%———
Revenue per Employee—$0.3M———
Opex per Employee—$0.3M———
S&M Expenses to Revenue33%34%38%33%34%
G&A Expenses to Revenue15%21%23%20%21%
R&D Expenses to Revenue12%14%17%14%14%
Opex to Revenue—84%93%82%84%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Definitive Healthcare Competitors

Definitive Healthcare competitors include JLK, DocCheck, CareCloud, Seer, Champions Oncology, Health Catalyst, Susmed, OptimizeRx, Omda and Oneview Healthcare.

Most Definitive Healthcare public comparables operate across Health Data & Analytics, Healthcare Software, B2B SaaS, Vertical SaaS and HealthTech.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
JLK34.7x—(10.2x)—
DocCheck1.1x—5.9x—
CareCloud0.8x0.7x3.3x3.3x
Seer(3.1x)(3.1x)1.2x1.3x
Champions Oncology1.4x—11.3x—
Health Catalyst0.5x0.5x3.8x4.1x
Susmed22.2x14.8x(37.7x)—
OptimizeRx0.9x0.9x4.1x4.2x

This data is available for Pro users. Sign up to see all Definitive Healthcare competitors and their valuation data.

Start Free Trial

Definitive Healthcare M&A Activity

Definitive Healthcare has acquired 7 companies to date.

Last acquisition by Definitive Healthcare was on August 14th 2023. Definitive Healthcare acquired Populi for $52M (EV/Revenue multiple of ).

See M&A valuation multiples

Latest Acquisitions by Definitive Healthcare

Populi
Analytical Wizards
Monocl
PatientFinder
Description
Populi is a healthcare analytics firm providing network optimization, consumer outreach, and physician engagement tools to health systems throughout the United States from its Nashville, Tennessee headquarters.
Analytical Wizards is a healthcare analytics firm headquartered in New York City. It applies AI and machine learning to pharma datasets for market access, forecasting, and patient journey optimization. The company serves 20+ biotech clients with platforms analyzing claims data from 300 million lives across US payers.
Monocl is a cloud-based platform for life sciences professionals enabling global expert mapping and engagement. Powered by machine learning, it analyzes data across therapeutic areas to deliver insights on key opinion leaders in oncology, immunology, and rare diseases. Headquartered in Boston, Monocl serves pharma companies in North America and Europe.
PatientFinder is a software analytics company that identifies patient clusters for life science firms and healthcare providers. Its tools analyze data to pinpoint groups most likely to benefit from specific therapies and services. The platform supports targeted marketing, clinical trial recruitment, and personalized care strategies. Operating from the United Kingdom, PatientFinder delivers insights drawn from vast healthcare datasets to optimize outreach and resource allocation.
HQ CountryUnited StatesUnited StatesUnited StatesUnited States
HQ City
Hartford, CT
—
—
Fort Lauderdale, FL
Deal Date14 Aug 202323 Feb 202229 Oct 202013 Jan 2020
Valuation$52M$70Mundisclosedundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Definitive Healthcare acquisitions and their M&A valuation multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Definitive Healthcare

When was Definitive Healthcare founded?Definitive Healthcare was founded in 2021.
Where is Definitive Healthcare headquartered?Definitive Healthcare is headquartered in United States.
How many employees does Definitive Healthcare have?As of today, Definitive Healthcare has over 782 employees.
Who is the CEO of Definitive Healthcare?Definitive Healthcare's CEO is Kevin D. Coop.
Is Definitive Healthcare publicly listed?Yes, Definitive Healthcare is a public company listed on Nasdaq.
What is the stock symbol of Definitive Healthcare?Definitive Healthcare trades under DH ticker.
When did Definitive Healthcare go public?Definitive Healthcare went public in 2021.
Who are competitors of Definitive Healthcare?Definitive Healthcare main competitors include JLK, DocCheck, CareCloud, Seer, Champions Oncology, Health Catalyst, Susmed, OptimizeRx, Omda, Oneview Healthcare.
What is the current market cap of Definitive Healthcare?Definitive Healthcare's current market cap is $89M.
What is the current revenue of Definitive Healthcare?Definitive Healthcare's last 12 months revenue is $235M.
What is the current revenue growth of Definitive Healthcare?Definitive Healthcare revenue growth (NTM/LTM) is (5%).
What is the current EV/Revenue multiple of Definitive Healthcare?Current revenue multiple of Definitive Healthcare is 0.3x.
Is Definitive Healthcare profitable?Yes, Definitive Healthcare is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of Definitive Healthcare?Definitive Healthcare's last 12 months EBITDA is $65M.
What is Definitive Healthcare's EBITDA margin?Definitive Healthcare's last 12 months EBITDA margin is 28%.
What is the current EV/EBITDA multiple of Definitive Healthcare?Current EBITDA multiple of Definitive Healthcare is 1.2x.
What is the current FCF of Definitive Healthcare?Definitive Healthcare's last 12 months FCF is $34M.
What is Definitive Healthcare's FCF margin?Definitive Healthcare's last 12 months FCF margin is 14%.
What is the current EV/FCF multiple of Definitive Healthcare?Current FCF multiple of Definitive Healthcare is 2.4x.
How many companies Definitive Healthcare has acquired to date?As of May 2026, Definitive Healthcare has acquired 7 companies.
What was the largest acquisition by Definitive Healthcare?$70M acquisition of Analytical Wizards on 23rd February 2022 was the largest M&A Definitive Healthcare has done to date.
What companies Definitive Healthcare acquired?Definitive Healthcare acquired Analytical Wizards, Populi, Billian's HealthDATA, US Lifeline, Monocl, HIMSS Analytics, and PatientFinder.
In how many companies Definitive Healthcare has invested to date?Definitive Healthcare hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Definitive Healthcare

Lists including Definitive Healthcare

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial